Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers

Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers

Small bowel adenocarcinoma (SBA), particularly duodenal adenocarcinoma (DA), is a rare gastrointestinal cancer with a dismal prognosis. Data on SBA treatments are limited, and the therapeutic strategy remains uncertain. Currently, chemotherapy is the most used treatment; however, it has a poor media...

Full description

Bibliographic Details
Main Authors: Xian Chen, Rui Zhou, Yong Li, Xin Qu, Yan-chun Qu, Wen-zhu Li, Yong-song Ye, Li-rong Liu, Yan-juan Zhu, Hai-bo Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
small bowel adenocarcinoma
duodenal adenocarcinoma
ICIS
immunotherapy
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1046513/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1046513/full

Similar Items